Your browser doesn't support javascript.
loading
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Tang, Tiffany; Martin, Peter; Somasundaram, Nagavalli; Lim, Cindy; Tao, Miriam; Poon, Eileen; Yunon, Maica Jd; Toh, Shu Q; Yan, Sean X; Farid, Mohamad; Chan, Jason Y; Lim, Soon T.
Afiliação
  • Tang T; Division of Medical Oncology, National Cancer Centre Singapore. Tiffany.Tang.P.L@singhealth.com.sg.
  • Martin P; Division of Medicine, Weill Cornell Medical College, New York.
  • Somasundaram N; Division of Medical Oncology, National Cancer Centre Singapore.
  • Lim C; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore.
  • Tao M; Division of Medical Oncology, National Cancer Centre Singapore.
  • Poon E; Division of Medical Oncology, National Cancer Centre Singapore.
  • Yunon MJ; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore.
  • Toh SQ; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore.
  • Yan SX; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital.
  • Farid M; Division of Medical Oncology, National Cancer Centre Singapore.
  • Chan JY; Division of Medical Oncology, National Cancer Centre Singapore.
  • Lim ST; Division of Medical Oncology, National Cancer Centre Singapore.
Haematologica ; 106(12): 3170-3175, 2021 12 01.
Article em En | MEDLINE | ID: mdl-33147935

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Ifosfamida Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T / Ifosfamida Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article